Miller, Edward Alan <br/><br/>
Incidence of new-onset diabetes mellitus among patients receiving atypical neuroleptics in the treatment of mental illness: evidence from a privately insured population.  [electronic resource] 

 -  The Journal of nervous and mental disease  Jun 2005 
 - 387-95 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0022-3018 
<br/><br/><label>Standard No.: </label>10.1097/01.nmd.0000165292.11527.16  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antipsychotic Agents--adverse effects<br/>Benzodiazepines--adverse effects<br/>Clozapine--adverse effects<br/>Diabetes Mellitus--chemically induced<br/>Dibenzothiazepines--adverse effects<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Incidence<br/>Insurance Coverage--statistics & numerical data<br/>Male<br/>Mental Disorders--drug therapy<br/>Olanzapine<br/>Proportional Hazards Models<br/>Quetiapine Fumarate<br/>Risk Factors<br/>Risperidone--adverse effects<br/>Sex Factors<br/>United States--epidemiology